-
1
-
-
18344380440
-
Ovarian cancer metastasis: Integrating insights from disparate model organisms
-
Naora H and Montell D (2005). Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 5, 355-366.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 355-366
-
-
Naora, H.1
Montell, D.2
-
3
-
-
19744368302
-
Cancer of the ovary
-
Cannistra SA (2004). Cancer of the ovary. N Engl J Med 351, 2519-2529.
-
(2004)
N Engl J Med.
, vol.351
, pp. 2519-2529
-
-
Cannistra, S.A.1
-
4
-
-
4344707226
-
Early events in ovarian oncogenesis
-
Cvetkovic D (2003). Early events in ovarian oncogenesis. Reprod Biol Endocrinol 1, 68.
-
(2003)
Reprod Biol Endocrinol
, vol.1
, pp. 68
-
-
Cvetkovic, D.1
-
5
-
-
0033050656
-
Markedly elevated levels of vascular endothelial growth factor in malignant ascites
-
Zebrowski B, Liu W, Ramirez K, Akagi Y, Mills G, and Ellis L (1999). Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol 6, 373-378.
-
(1999)
Ann Surg Oncol
, vol.6
, pp. 373-378
-
-
Zebrowski, B.1
Liu, W.2
Ramirez, K.3
Akagi, Y.4
Mills, G.5
Ellis, L.6
-
6
-
-
4143151913
-
Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy
-
Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, Tanaka Y, Yagi H, Sonoda K, and Kai M (2004). Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res 64, 5720-5727.
-
(2004)
Cancer Res
, vol.64
, pp. 5720-5727
-
-
Miyamoto, S.1
Hirata, M.2
Yamazaki, A.3
Kageyama, T.4
Hasuwa, H.5
Mizushima, H.6
Tanaka, Y.7
Yagi, H.8
Sonoda, K.9
Kai, M.10
-
7
-
-
17144460494
-
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer
-
Mills G, Eder A, Fang X, Hasegawa Y, Mao M, Lu Y, Tanyi J, Tabassam F, Wiener J, Lapushin R, et al. (2002). Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Cancer Treat Res 107, 259-283.
-
(2002)
Cancer Treat Res
, vol.107
, pp. 259-283
-
-
Mills, G.1
Eder, A.2
Fang, X.3
Hasegawa, Y.4
Mao, M.5
Lu, Y.6
Tanyi, J.7
Tabassam, F.8
Wiener, J.9
Lapushin, R.10
-
8
-
-
0032968752
-
Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer
-
Saltzman A, Hartenbach E, Carter J, Contreras D, Twiggs L, Carson L, and Ramakrishnan S (1999). Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer. Gynecol Obstet Invest 47, 200-204.
-
(1999)
Gynecol Obstet Invest
, vol.47
, pp. 200-204
-
-
Saltzman, A.1
Hartenbach, E.2
Carter, J.3
Contreras, D.4
Twiggs, L.5
Carson, L.6
Ramakrishnan, S.7
-
9
-
-
0033941392
-
Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells
-
Abendstein B, Stadlmann S, Knabbe C, Buck M, Muller-Holzner E, Zeimet A, Marth C, Obrist P, Krugmann J, and Offner F (2000). Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells. Cytokine 12, 1115-1119.
-
(2000)
Cytokine
, vol.12
, pp. 1115-1119
-
-
Abendstein, B.1
Stadlmann, S.2
Knabbe, C.3
Buck, M.4
Muller-Holzner, E.5
Zeimet, A.6
Marth, C.7
Obrist, P.8
Krugmann, J.9
Offner, F.10
-
10
-
-
33846815431
-
Ascites and epithelial ovarian cancers: A reappraisal with respect to different aspects
-
Ayhan A, Gultekin M, Taskiran C, Dursun P, Firat P, Bozdag G, Celik NY, and Yuce K (2007). Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects. Int J Gynecol Cancer 17, 68-75.
-
(2007)
Int J Gynecol Cancer
, vol.17
, pp. 68-75
-
-
Ayhan, A.1
Gultekin, M.2
Taskiran, C.3
Dursun, P.4
Firat, P.5
Bozdag, G.6
Celik, N.Y.7
Yuce, K.8
-
11
-
-
35448943030
-
Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer
-
Puiffe M-L, Le Page C, Filali-Mouhim A, Zietarska M, Ouellet V, Tonin N, Chevrette M, Provencher D, and Mes-Masson A (2007). Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia 9, 820-829.
-
(2007)
Neoplasia
, vol.9
, pp. 820-829
-
-
Puiffe, M.-L.1
le Page, C.2
Filali-Mouhim, A.3
Zietarska, M.4
Ouellet, V.5
Tonin, N.6
Chevrette, M.7
Provencher, D.8
Mes-Masson, A.9
-
12
-
-
0033869716
-
Characterization of four novel epithelial ovarian cancer cell lines
-
Provencher D, Lounis H, Champoux L, Tetrault M, Manderson E, Wang J, Eydoux P, Savoie R, Tonin P, and Mes-Masson A (2000). Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell Dev Biol Anim 36, 357-361.
-
(2000)
Vitro Cell Dev Biol Anim
, vol.36
, pp. 357-361
-
-
Provencher, D.1
Lounis, H.2
Champoux, L.3
Tetrault, M.4
Manderson, E.5
Wang, J.6
Eydoux, P.7
Savoie, R.8
Tonin, P.9
Mes-Masson, A.10
-
13
-
-
0035807230
-
Microarray analysis of gene expression mirrors the biology of an ovarian cancer model
-
Tonin N, Hudson T, Rodier F, Bossolasco M, Lee PD, Novak J, Manderson EN, Provencher D, and Mes-Masson A (2001). Microarray analysis of gene expression mirrors the biology of an ovarian cancer model. Oncogene 20, 6617-6626.
-
(2001)
Oncogene
, vol.20
, pp. 6617-6626
-
-
Tonin, N.1
Hudson, T.2
Rodier, F.3
Bossolasco, M.4
Lee, P.D.5
Novak, J.6
Manderson, E.N.7
Provencher, D.8
Mes-Masson, A.9
-
14
-
-
0025322319
-
A simplified method to culture human ovarian surface epithelium
-
Kruk P, Maines-Bandiera S, and Auersperg N (1990). A simplified method to culture human ovarian surface epithelium. Lab Invest 63, 132-136.
-
(1990)
Lab Invest
, vol.63
, pp. 132-136
-
-
Kruk, P.1
Maines-Bandiera, S.2
Auersperg, N.3
-
15
-
-
0037336331
-
Open source software for the analysis of microarray data
-
Dudoit S, Gentleman R, and Quackenbush J (2003). Open source software for the analysis of microarray data. Biotechniques (Suppl), 45-51.
-
(2003)
Biotechniques
, Issue.SUPPL.
, pp. 45-51
-
-
Dudoit, S.1
Gentleman, R.2
Quackenbush, J.3
-
17
-
-
17344392308
-
A new mathematical model for relative quantification in realtime RT-PCR
-
Pfaffl M (2001). A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29, e45.
-
(2001)
Nucleic Acids Res
, vol.29
-
-
Pfaffl, M.1
-
18
-
-
47549114934
-
Characterization of three new serous epithelial ovarian cancer cell lines
-
Ouellet V, Zietarska M, Portelance L, Lafontaine J, Madore J, Puiffe M, Arcand S, Shen Z, Hébert J, Tonin P, et al. (2008). Characterization of three new serous epithelial ovarian cancer cell lines. BMC Cancer 8, 152.
-
(2008)
BMC Cancer
, vol.8
, pp. 152
-
-
Ouellet, V.1
Zietarska, M.2
Portelance, L.3
Lafontaine, J.4
Madore, J.5
Puiffe, M.6
Arcand, S.7
Shen, Z.8
Hébert, J.9
Tonin, P.10
-
20
-
-
0037260139
-
Cancer statistics
-
Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, and Thun MJ (2003). Cancer statistics. CA Cancer J Clin 53, 5-26.
-
(2003)
CA Cancer J Clin
, vol.53
, pp. 5-26
-
-
Jemal, A.1
Murray, T.2
Samuels, A.3
Ghafoor, A.4
Ward, E.5
Thun, M.J.6
-
21
-
-
33745967290
-
Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property
-
Jandu N, Richardson M, Singh G, Hirte H, and Hatton MWC (2006). Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property. Int J Gynecol Cancer 16, 1536-1544.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 1536-1544
-
-
Jandu, N.1
Richardson, M.2
Singh, G.3
Hirte, H.4
Hatton, M.W.C.5
-
22
-
-
0036919935
-
Ascites as a predictor of ovarian malignancy
-
Shen-Gunther J and Mannel RS (2002). Ascites as a predictor of ovarian malignancy. Gynecol Oncol 87, 77-83.
-
(2002)
Gynecol Oncol
, vol.87
, pp. 77-83
-
-
Shen-Gunther, J.1
Mannel, R.S.2
-
23
-
-
13444266042
-
Catalytically inactive human cathepsin D triggers fibroblast invasive growth
-
Laurent-Matha V, Maruani-Herrmann S, Prébois C, Beaujouin M, Glondu M, Noël A, Alvarez-Gonzalez ML, Blacher S, Coopman P, Baghdiguian S, et al. (2005). Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J Cell Biol 168, 489-499.
-
(2005)
J Cell Biol
, vol.168
, pp. 489-499
-
-
Laurent-Matha, V.1
Maruani-Herrmann, S.2
Prébois, C.3
Beaujouin, M.4
Glondu, M.5
Noël, A.6
Alvarez-Gonzalez, M.L.7
Blacher, S.8
Coopman, P.9
Baghdiguian, S.10
-
24
-
-
0037264633
-
Targeting Ras signalling pathways in cancer therapy
-
Downward J (2002). Targeting Ras signalling pathways in cancer therapy. Nat Rev Cancer 3, 11-22.
-
(2002)
Nat Rev Cancer
, vol.3
, pp. 11-22
-
-
Downward, J.1
-
25
-
-
34547621066
-
Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice
-
Parikh C, Subrahmanyam R, and Ren R (2007). Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice. Cancer Res 67, 7139-7146.
-
(2007)
Cancer Res
, vol.67
, pp. 7139-7146
-
-
Parikh, C.1
Subrahmanyam, R.2
Ren, R.3
-
26
-
-
18944402351
-
1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma
-
1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br J Cancer 92, 1475-1485.
-
(2005)
Br J Cancer
, vol.92
, pp. 1475-1485
-
-
Ahmed, N.1
Riley, C.2
Oliva, K.3
Rice, G.4
Quinn, M.5
-
27
-
-
34547109890
-
Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer
-
Kaneko R, Tsuji N, Asanuma K, Tanabe H, Kobayashi D, and Watanabe N (2007). Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer. J Biol Chem 282, 19273-19281.
-
(2007)
J Biol Chem
, vol.282
, pp. 19273-19281
-
-
Kaneko, R.1
Tsuji, N.2
Asanuma, K.3
Tanabe, H.4
Kobayashi, D.5
Watanabe, N.6
-
28
-
-
4544268945
-
ETS transcription factors: Possible targets for cancer therapy
-
Oikawa T (2004). ETS transcription factors: possible targets for cancer therapy. Cancer Sci 95, 626-633.
-
(2004)
Cancer Sci
, vol.95
, pp. 626-633
-
-
Oikawa, T.1
-
29
-
-
7644237126
-
Involvement of insulin receptor substrate 2 in mammary tumor metastasis
-
Nagle J, Ma Z, Byrne M, White M, and Shaw L (2004). Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol 24, 9726-9735.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 9726-9735
-
-
Nagle, J.1
Ma, Z.2
Byrne, M.3
White, M.4
Shaw, L.5
-
31
-
-
0035138697
-
CD44 and β1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins
-
Casey RC and Skubitz A (2000). CD44 and β1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin Exp Metast 18, 67-75.
-
(2000)
Clin Exp Metast
, vol.18
, pp. 67-75
-
-
Casey, R.C.1
Skubitz, A.2
-
32
-
-
0030895244
-
In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: A novel role for CD44 in the process of peritoneal implantation
-
Strobel T, Swanson L, and Cannistra SA (1997). In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation. Cancer Res 57, 1228-1232.
-
(1997)
Cancer Res
, vol.57
, pp. 1228-1232
-
-
Strobel, T.1
Swanson, L.2
Cannistra, S.A.3
-
33
-
-
61349189010
-
CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance
-
Klingbeil P, Marhaba R, Jung T, Kirme R, Ludwig T, and Zöller M (2009). CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance. Mol Cancer Res 7, 168-179.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 168-179
-
-
Klingbeil, P.1
Marhaba, R.2
Jung, T.3
Kirme, R.4
Ludwig, T.5
Zöller, M.6
-
34
-
-
0347624593
-
Role for BRG1 in cell cycle control and tumor suppression
-
Hendricks K, Shanahan F, and Lees E (2004). Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol 24, 362-376
-
(2004)
Mol Cell Biol
, vol.24
, pp. 362-376
-
-
Hendricks, K.1
Shanahan, F.2
Lees, E.3
-
35
-
-
1642540254
-
BRG1 controls the activity of the retinoblastoma protein via regulation of p21 (CIP1/WAF1/SDI)
-
Kang H, Cui K, and Zhao K (2004). BRG1 controls the activity of the retinoblastoma protein via regulation of p21 (CIP1/WAF1/SDI). Mol Cell Biol 24, 1188-1199.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 1188-1199
-
-
Kang, H.1
Cui, K.2
Zhao, K.3
|